| Actual |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Debt Consolidation > Consolidate Debt to your Credit Cards |
|
Actual - Consolidate Debt to your Credit Cards
Credit card companies are constantly looking for ways to get more customers. One way they do thi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s is by offering extremely low interest rates for people who want to move a large balance to the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in cards. For many people this looks attractive because it is an easy way to get a debt consolidat lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ion loan with virtually no fees. While this isn’t necessarily a bad strategy, you need to make s here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ure you read the fine print and have a solid plan for what to do once the introductory period is d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro over. Some credit companies will offer you 0% interest for a year, but after the year the rate ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc jumps to 20%. If you don’t understand all of the little details of the loan, you may find yours easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi elf worse off than before. Using plastic credit in this way can be a good thing if it helps you nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically get out of debt. However, if the additional credit becomes a temptation and causes you to go dee and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ per into debt than before the low interest loan can do more harm than good. If you are looking ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi at using a credit card for this, make sure you understand exactly what the terms are. Also make ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a sure you keep a copy of the terms so you have them to backup any dispute you may have. In additi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod on you need to have a plan for what to do if you are unable to pay off the balance by the time t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin he rate goes back up. For example you might want to take out a home equity loan on your house to tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pay off the balance. Some people may even have the cash available, but would rather earn intere t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel st on their money instead of pay off the debt. For those people they can just pay off the balanc ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e from their savings (or look for another great credit card deal). The problem with this type o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products f strategy is the fact that it is very easy to spend money, but difficult to control it. For man . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y people just having a larger line of credit available will be too much of a temptation. If you elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip are able to discipline your spending however, these credit card deals can work to your advantage tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Why a Permanent Job is Bad for You (1) Gourment Cookies and a Wholesale, Drop Ship Business - HUH? Taking It from Chapels to Cubicles
|